Vir Biotechnology

Share on: 
Description: 

Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.  Vir Biotechnology will be partnering with Alnylam Pharmaceuticals to identify siRNA therapeutics to treat COVID-19. Vir Biotechnology has also identified two monoclonal antibodies that bind to SARS-CoV-2 and is working with WuXi Biologics to commercialize them. These antibodies target the spike (S) protein of the virus by entering through the cellular receptor ACE2.

Location(s): 
San Francisco CA
United States